🧬 Biotech + New York, NY
Discover 10 venture capital firms investing in Biotech and headquartered in New York, NY. This directory highlights investors with active biotech portfolios and a local presence in New York, NY, helping founders identify the right capital partners for their next raise. Browse firm profiles, compare check sizes and stage focus, and find investors who understand both the biotech landscape and the New York, NY startup ecosystem.
10 firms
New York, NY is home to 10+ venture capital firms that specialize in Biotech. The top firms combine deep Biotech expertise with local New York, NY networks, deal flow, and industry connections.
Start by reviewing the 10 Biotech-focused VCs based in New York, NY ranked on this page. Evaluate each firm's stage focus, check size, and portfolio to find the best fit for your startup's needs.
New York, NY has an active Biotech investment community with firms specializing in this sector. Local investors bring valuable industry connections and ecosystem advantages specific to the New York, NY market.
Founded 2002, invests in disruptive life, physical, and data sciences
Pre-seed firm guaranteeing funds in 10 business days.
KittyHawk Ventures is a New York-based venture firm that invests across the capital stack, from frontier seed rounds all the way through pre-IPO growth equity, focusing on transformative technology companies in sectors including fintech, enterprise software, and aerospace. The firm takes a flexible, stage-agnostic approach that allows it to build concentrated positions in breakout companies over multiple rounds. KittyHawk is known for its long-term partnership model and willingness to back unconventional founders with bold visions.
Deep technology venture firm investing in emerging science and technology ventures in energy, healthcare, and defense.
Early institutional backer sourcing tech from academia and government labs.
New York-based deep tech investor backing science-driven companies in defense, robotics, space, and computational biology.
Leading healthcare-dedicated investment firm with over $18B under management, investing across biotech, pharma, and medtech.
Healthcare-only platform spanning seed through IPO via public/private arms.
Healthcare-focused venture arm of Venrock, the Rockefeller family venture fund, investing in biotech and digital health.
Deep technology venture firm investing in companies at the intersection of science and engineering, from seed through growth.